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A B S T R A C T
Purpose: Myopia is a global public health issue; however, no information exists as to how potential
myopia retardation strategies are being adopted globally.
Methods: A self-administrated, internet-based questionnaire was distributed in six languages, through
professional bodies to eye care practitioners globally. The questions examined: awareness of increasing
myopia prevalence, perceived efﬁcacy and adoption of available strategies, and reasons for not adopting
speciﬁc strategies.
Results: Of the 971 respondents, concern was higher (median 9/10) in Asia than in any other continent (7/
10, p < 0.001) and they considered themselves more active in implementing myopia control strategies (8/
10) than Australasia and Europe (7/10), with North (4/10) and South America (5/10) being least proactive
(p < 0.001). Orthokeratology was perceived to be the most effective method of myopia control, followed
by increased time outdoors and pharmaceutical approaches, with under-correction and single vision
spectacles felt to be the least effective (p < 0.05). Although signiﬁcant intra-regional differences existed,
overall most practitioners 67.5 (37.8)% prescribed single vision spectacles or contact lenses as the
primary mode of correction for myopic patients. The main justiﬁcations for their reluctance to prescribe
alternatives to single vision refractive corrections were increased cost (35.6%), inadequate information
(33.3%) and the unpredictability of outcomes (28.2%).
Conclusions: Regardless of practitioners’ awareness of the efﬁcacy of myopia control techniques, the vast
majority still prescribe single vision interventions to young myopes. In view of the increasing prevalence
of myopia and existing evidence for interventions to slow myopia progression, clear guidelines for
myopia management need to be established.
ã 2016 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.
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The prevalence of myopia has approximately doubled in the
past three decades [1–3], arguably reaching epidemic levels.
Prevalence rates of 70–87% have been reported amongst pop-
ulations of schoolchildren and young adults in Asia [1,4–8], and
around 20–50% in America and Europe [9–12]. Moreover, the onset
of myopia in the last two generations has been reported to occur
earlier [1,13,14] leading to an increased prevalence of high myopia
( 6.00 D). High myopia is strongly associated with an increased
risk of sight-threatening pathological ocular comorbidities, [1,15]
including retinal detachment, glaucoma, and cataract [16–21]. A
study conducted in Taiwan [1], comparing the age of onset and
prevalence of myopia amongst schoolchildren from 1983 to 2000,
shows an alarming shift towards a more myopic refractive error in
recent years; in 1983, the mean onset of myopia was 11 years,
whereas, in 2000, it was eight years; the mean refractive status
observed at eight years of age was 0.45 1.03 D and 0.15 1.40 D
in 1983 and 2000, respectively, whereas at 11 years of age it was
0.27  1.72 D and 1.20  1.93 D, respectively.
A range of factors including genetic predisposition [22–27],
inadequate near accommodation response [28,29], elevated AC/A
ratio/esophoria [30,31], excessive time spent undertaking near
work [25,32–34], low levels of outdoor activity [35–39], lighting
levels [36,40,41] and the magnitude of hyperopic peripheral
defocus [42–50] have been linked to the development and/or
progression of myopic refractive error. However, the exact
mechanisms surrounding both myopia development and progres-
sion are not yet fully understood as the disease appears to be
multifactorial in nature.
Over the past few years, there has been signiﬁcant research and
clinical interest in so-called ‘myopia control’ approaches, being
clinical methods which are designed to be beneﬁcial for
attenuating childhood myopic progression. Sankaridurg and
Holden [51] discussed the potential beneﬁt that a six year-old
east-Asian child with 1.00 D of myopia could have, at age 15 years,
if myopia progression was reduced by 30.0%, using an evidence-
based model of progression rates of myopia. If this child’s myopiaFig. 1. Comparative studies [53–76] of the effectiveness (over the evaluateprogressed at the rate predicted by available natural history data,
they would be expected to develop myopia in the order of 7.00 D
by 15 years of age. If the myopia progression had been retarded by
an estimated 30% over the eight-year follow-up period, then
5.50 D of myopia would be predicted. In a review paper, Flitcroft
[17] highlighted that the higher the myopic refraction, the higher
the odds ratio for myopic maculopathy, retinal detachment and, to
a lesser extent, glaucoma and cataract. For example, compared to
an emmetropes, the odds ratio for developing myopic maculopathy
is 40.6 (95% conﬁdence interval: 13.3–124.4) for myopia of 5.00 to
6.99 D, but increases to 126.8 (34.0–472.3) for myopia of 7.00 to
8.99 D [17,21]. Similarly, the odds ratio for developing retinal
detachment is 21.5 (17.3–26.7) for myopia of 5.00 to 6.99 D, but
increases to 44.2 (34.2–57.2) for myopia of 7.00 to 8.99 D [17,52].
It has been estimated that reducing the rate of myopia progression
by 33% would lead to a reduction of 73% in the frequency of high
myopia (<5.00 D) [53]. Lower levels of myopia have a reduced
risk, but as the number of people with lower levels of myopia is
greater, the public health risk of any myopia is still signiﬁcant [17].
Multiple options are currently available for myopic refractive
correction, including single vision, bifocal and progressive addition
lens (PALs) spectacles, soft and rigid contact lenses (including
orthokeratology) and refractive surgery. However, the relative
contribution of these clinical methods for retarding myopia
progression has only been more thoroughly investigated in more
recent years (Fig. 1) [54–76].
It has been suggested that conventional single vision spectacle
lenses may be ineffective for myopia control as they induce
peripheral hyperopic defocus, a factor speculated to promote eye
growth [47,48,77,78]. However some authors have questioned
whether peripheral eye focus is the primary mechanism driving
eye growth, as they reported that some myopic children wearing
single vision spectacles had greater relative myopic defocus, and
thus myopia progression was less than it was in those children
wearing single vision spectacles with relatively greater hyperopic
defocus [67,79]. Other large studies in humans have also found
peripheral refraction to neither affect myopia onset or develop-
ment [64,80]. Progressive addition and bifocal lenses have beend period) of different techniques to retard the progression of myopia.
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blur associated with increased lag of accommodation in myopia
[28,29,31,64]. It is presumed that an insufﬁcient amount of
accommodation might cause a relative retinal blur and, hence,
be a triggering factor for axial elongation. The success rate of
studies employing PALs and bifocals have varied from no effect
[65,81] to 46% for PALs (although this study was not randomised)
[66], and 44–56% for bifocals and executive bifocals [59,61].
However, other studies have reported retardation rates of 14% to
24% [60,64,66,82,83] which are less convincing.
Under-correction, which was believed not only to reduce
accommodative demand, but induce myopic defocus, has been
hypothesised to act as a halting signal to myopia development in
animal studies [84,85]. Contrarily, under-correction has been
found to accelerate the rate of myopia progression by 17–29% in
human clinical studies [57,58].
Soft single vision contact lenses [86–88] and conventional rigid
gas permeable (RGP) contact lenses [87,89,90] have been found to
have no effect on myopia progression. However, multifocal contact
lens designs appear to be effective in reducing myopia progression
(by 34–50%) and may be more effective than bifocal or PAL
spectacle lens designs; this may result from the optics of a contact
lens, including the near portion, being consistently aligned with
the position of gaze because the lens moves with the eye [64,71,91],
and possibly more consistency in wearing time which seems to be
an important factor for efﬁcacy [92]. Orthokeratology studies are
remarkably consistent in the level of myopia retardation shown,
being around 50% [74–76] and is considered at present the optical
treatment with the strongest accumulated evidence [93].
Pharmaceutical treatment strategies, such as atropine
[56,81,94] and pirenzepine [55,95,96], have shown high success
rates (32% to 72%). However, there has been a lack of consensus for
the optimum concentration to prevent unwanted side-effects
during treatment, and the rebound effect following cessation of
treatment [55,59,83,97,98].
Epidemiology studies in the general population, and in
monozygotic twins, have generally demonstrated that time spent
outdoors reduces the likelihood of myopia onset [99–102]. The
behavioural approach of increased outdoor activity has been
shown to retard the onset of myopia by 11–34% [54]. It is
postulated that the higher luminance levels, which exist outdoors
compared to indoors, trigger the release of the retinal transmitter,
dopamine, which is believed to prevent axial growth and myopia
development [36,40,41]. In addition, it has been suggested that
components of sunlight itself could activate particularly vitamin D,
which could play a potential role in preventing eye growth
[36,103]. Furthermore, viewing distances are generally greater
outdoors compared to indoors, removing accommodative demand
and retinal image quality could improve as pupil diameter is
smaller in bright light, increasing depth of focus [38].
However, if and how these approaches are employed in clinical
practice is still unclear. In 2013 the Vision Research Institute
(Ferris State University Michigan Collage of Optometry) con-
ducted a survey concerning the increasing rates of myopia
prevalence (available online: http://www.myopiacontrol.org/
how-do-you-myopia-control-.html). Results showed that practi-
tioners in United States of America were aware of the growing
issue and tended to familiarise themselves with the current
literature in the ﬁeld. However, their rationale for prescribing, or
the frequency of choosing different management strategies was
not included in the survey. Likewise, Contact Lens Spectrum has
also surveyed over 400 practitioners in the United States of
America in both 2014 and 2015 showing that in both years, 24% of
practitioners report using contact lenses to control myopia;
practitioners reported using soft multifocals and orthokeratology
contact lens designs predominantly, with very few reporting rigidmultifocals [104]. Several studies have reported statistically, but
not clinically, signiﬁcant reductions in the rates of myopia
progression retardation (see Fig. 1) and some authors doubt the
retardation effect achieved [60], presumably leaving practitioners
confused and sceptical about the various management strategies
available. Therefore, a better understanding of current trends of
myopia management in clinical practice is required before
targeted education and recommended criteria for intervention
can be introduced.
2. Method
A self-administrated, internet-based cross-sectional survey in
English, French, Spanish, Italian, Portuguese and Chinese was
distributed using software SurveyMonkey (Palo Alto, California,
USA) through various professional bodies across the world to
reach eye care professionals (optometrists, dispensing opticians,
ophthalmologists and others) globally. The survey comprised of
nine questions relating to the self-reported clinical management
behaviours of practitioners for progressive myopia and practi-
tioner’s current opinions on myopia related clinical care includ-
ing:
 level of concern about the increasing frequency of paediatric
myopia in their clinical practice (rated as ‘Not at all,’ to
‘extremely,’ on a 10 point scale)
 perceived effectiveness, deﬁned as the expected level of
reduction in childhood myopia progression of a range of myopia
control options (rated as a percentage from 0 to 100%)
 how active they would consider their clinical practice in the area
of myopia control (rated as ‘Not at all,’ to ‘fully,’ on a 10 point
scale)
 frequency of prescribing different myopia correction options for
progressive/young myopes during a typical month
 minimum age a patient would need to be for them to consider
myopia refractive correction options (assuming average han-
dling skills and child/parent motivation)
 minimum amount of myopia that would need to be present to
consider myopia refractive correction options (speciﬁed in half
dioptre steps)
 minimum level of myopia progression that would prompt a
practitioner to speciﬁcally adopt a myopia control approach
(speciﬁed in quarter dioptre steps)
 frequency of adopting single vision under-correction as a
strategy to slow myopia progression (reported as ‘no,’ ‘some-
times,’ or ‘always’)?
 if they had only ever ﬁtted single vision spectacles/contact lenses
for myopic patients, what had prevented them (multiple options
could be selected) from prescribing alternative refractive
correction methods; options consisted of:
 They don’t believe that these are any more effective
 The outcome is not predictable
 Safety concerns
 Cost to the patient makes them uneconomical
 Additional chair time required
 Inadequate information/knowledge
 Beneﬁt/risk ratio
 Other
There was an option to add further comments to each of the
questions and the topic as a whole. Voluntary participation in the
survey, following an explanation of the research, was anonymous,
however, respondents were asked to provide basic demographic
information about themselves (highest qualiﬁcation, years of being
qualiﬁed and everyday working environment). The data was
collected between January and June 2015.
Fig. 2. Level of practitioner concern (rated from 0 to 10) regarding the perceived
increasing frequency of paediatric myopia in their practice for practitioners located
in different continents. N = 964. Error bars = 1 SD.
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Statistical analysis was conducted with SPSS (v21 IBM, New
York, USA). Only complete surveys were analysed. Median, mean
and standard deviations were calculated for each question
response, with the results grouped by continent (Asia, Australasia,
Europe, North America and South America) and countries within a
continent where response rate allowed (n  30), with Kruskal-
Wallis tests applied to determine statistical difference (taken as
p < 0.05) between them. For conciseness, only signiﬁcant compar-
isons have been reported.
3. Results
3.1. Responses
The total number of 971 complete survey responses were
received, with the distribution by continent being: Africa 7 (not
included in further analysis), Asia 291, Australasia 119; Europe 339;
North America 133; and South America 82. Country speciﬁc
responses could be extracted from:
 Europe: France (n = 34), Italy (n = 72), Netherlands (n = 38)
Portugal (n = 48),
 Spain (n = 34) and UK/EIRE (n = 52)
 Asia: China (n = 137), Hong Kong (n = 61) and India (n = 37)
 North America; Canada (n = 33) and USA (n = 100)
Of the study participants, 72.4% (n = 698) were optometrists,
18.6% (n = 180) were ophthalmologists, 5.8% (n = 56) were contact
lens opticians and 3.2% (n = 31) were other types of eye care
specialists. The principal working environment for 84.4% was in
clinical practice (n = 814), 11.3% worked in academia (n = 109), 1.6%
worked within industry (n = 16) and 2.7% (n = 26) worked in other
environments. However, all study participants were registered eye
care practitioners. The median number of years qualiﬁed was the
11–20 category, with a normally distributed spread.
3.2. Self-reported concern about the increasing frequency of paediatric
myopia (Fig. 2)
Practitioners’ concern about increasing frequencies of paediat-
ric myopia in their practices was higher (median 9/10) in Asia than
any of the other continents (p < 0.001), with a similar level of
concern (all with a median of 7/10; p > 0.05) across Australasia,
Europe, North and South America. In Asia, Chinese practitioners
were more concerned (8.8  1.5) than those in Hong Kong
(7.9  1.7; p = 0.001) or India (7.3  2.6; p = 0.002). In Europe,Table 1
Perceived effectiveness (deﬁned as the expected level of reduction in childhood myop
continents. Data are expressed as mean  S.D.
Continent
Technique Asia Au
Spectacles Under-correction 6.5  13.9 2
Single Vision 16.0  23.6 4
Bifocals 18.4  21.1 14
Progressive Addition (PALs) 21.3  21.2 16
Contact Lenses Rigid Gas Permeable (RGP) 23.9  26.9 9
Single Vision Soft 11.9  20.6 4
Multifocal Soft 15.5  20.2 22
Novel Myopia Control Soft 24.4  26.0 29
Orthokeratology 48.6  29.6 47
Pharmaceutical 31.7  27.8 39
Refractive Surgery 17.4  29.7 11
Increased Time Outdoors 38.7  27.5 29Portuguese (8.2  3.2) and Spanish (8.3  2.3) practitioners were
more concerned than those in Italy (6.9  2.5; p = 0.046,
p = 0.027 respectively), the Netherlands (6.3  2.1; p = 0.002,
p = 0.001) or the UK/EIRE (5.8  2.6; p < 0.001, p < 0.001). In North
America, practitioners from the USA (6.8  2.7) were more
concerned than their Canadian neighbours (5.4  2.7; p = 0.005) .
3.3. Perceived effectiveness of myopia control options (Table 1)
Overall, orthokeratology was perceived by practitioners to be
the most effective method of myopia control, followed by
increased time outdoors and pharmaceutical approaches. Single
vision distance under-correction and single vision spectacles were
perceived to be the least effective method. These ﬁndings were
consistent across all continents except for South America
(p < 0.05), where all the modalities were perceived to be similarly
effective (12–24%), except for time spent outdoors (35%).
Compared with practitioners from all other continents, Asians
practitioners considered single vision, bifocal and progression
addition lenses to be relatively more effective for reducing
childhood myopia progression (p < 0.01). Australian and North
American practitioners perceived single vision contact lenses as
less effective than practitioners from other continents (p < 0.01).
North American practitioners had less conﬁdence in orthoker-
atology and pharmaceuticals as appropriate methods for myopia
control than those from Asia or Australasia (p = 0.001); the sameia progression in percent) of myopia control options by practitioners in different
stralasia Europe North America South America
.5  7.4 6.4  15.8 2.9  7.9 13.4  23.1
.2  12.5 10.0  21.8 4.0  14.0 18.1  30.7
.1  14.8 12.4  17.5 11.6  14.4 12.3  24.2
.0  14.0 14.7  18.6 11.3  13.5 12.8  24.8
.6  13.8 14.1  20.8 9.9  15.4 13.6  27.0
.1  11.5 10.1  20.5 2.9  10.5 16.0  29.0
.5  19.3 16.4  25.7 18.4  20.5 11.5  19.7
.1  19.3 25.2  25.7 21.5  23.1 18.8  28.5
.8  25.3 44.3  29.0 36.9  30.1 23.9  32.3
.0  32.4 24.2  29.4 21.8  27.0 14.6  23.3
.4  24.3 12.8  25.6 13.5  30.6 18.0  29.4
.7  22.0 29.4  26.2 20.5  17.9 35.3  32.0
Fig. 3. Perceived level of clinical activity in the area of myopia control for
practitioners located in different continents. N = 964. Error bars = 1 SD.
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icals (p < 0.001). North Americans were also more sceptical about
the potential beneﬁt of increasing time spent outdoors on myopia
progression compared with practitioners from other continents
(p < 0.05). Intra-region comparisons showed that there were wide
variations in perceived effectiveness across all myopia control
options .
3.4. Perceived level of clinical activity in the area of myopia control
(Fig. 3)
Asian practitioners considered their clinical practice of myopia
control to be more active (median 8/10) than practitioners from
Australasian (median 7/10; p = 0.028), European (median 7/10;
p < 0.001), North American (median 4/10; p < 0.001) or South
American practitioners (median 5/10, p < 0.001). North American
practitioners perceived themselves to be relatively less active in
this area of practice than those from Europe (p < 0.001) and
Australasia (p < 0.001). Within Europe there were no differences
between countries, however, within Asia, Indian practitioners
(6.05 1.99) considered themselves relatively less active than
Chinese (7.96  1.96; p < 0.001) or Hong Kong (7.31  2.20;
p = 0.002) practitioners. Within North America, Canadian practi-
tioners (3.97  3.42) considered themselves less active than those
from the USA (4.96  2.83; p = 0.034) .Table 2
Frequency of prescribing myopia correction options for progressing/young myopes by pra
as mean  S.D.
Continent
Technique Asia Au
Spectacles Single Vision 57.6  31.3 36
Bifocals 2.9  7.3 1
Progressive Addition (PALs) 7.4  13.3 17
Contact Lenses Rigid Gas Permeable (RGP) 4.9  8.5 0
Single Vision Soft 5.7  9.9 13
Multifocal Soft 0.8  2.9 6
Novel Myopia Control Soft 2.2  8.1 1
Orthokeratology 11.1  17.6 21
Pharmaceutical 5.6  14.5 0
Refractive Surgery 2.0  8.3 03.5. Frequency of prescribing different myopia correction options for
progressing/young myopes (Table 2)
The majority of progressing myopes were being prescribed
either single vision (full correction) spectacles (47.8  31.7%) or
single vision contact lenses (15.2  17.3%). Orthokeratology
(14.3  24.3%), PAL spectacles (6.5 14.3%), RGPs (4.5 10.5%),
multifocal contact lenses (4.1 11.3%), bifocal spectacles
(2.6  8.2%), novel myopia control contact lenses (2.1 7.9%),
pharmaceuticals (1.9  8.7%) and refractive surgery (1.0  5.4%)
were utilised relatively less frequency. Asian practitioners indicat-
ed prescribing single vision (full correction) spectacles most
frequently, whereas those from Australia prescribed them least
often (p < 0.001). North American practitioners indicated prescrib-
ing bifocal spectacles most frequently (p < 0.001) for progressing/
young myopes. Australian practitioners, and to a lesser degree,
Asian practitioners, prescribed PALs more frequently (p < 0.001)
than those from other continents. Australians and North American
practitioners prescribed RGPs (p < 0.001) less frequently to these
patients. Asian practitioners prescribe single vision contact lenses
(p < 0.001) least often, while North American practitioners
prescribed more standard multifocal contact lenses (p < 0.001)
than other regions. Few novel myopia control soft contact lenses
are being prescribed in any continent. South American practi-
tioners prescribed orthokeratology least frequently (p < 0.001).
Asian practitioners indicated utilising pharmaceuticals more
frequently (p < 0.001) than practitioners from other continents
for progressing/young myopes. Asian and South American practi-
tioners recommended refractive surgery more than other con-
tinents for these patients, but the prescribing frequency was still
low (p < 0.001). Intra-region comparison showed large variations
in prescribing habits for all myopia control options .
3.6. Minimum patient age that practitioners consider myopia
correction options (Table 3)
Single vision spectacles were prescribed from the youngest age
(5.4 1.5 years). Multifocal spectacles (bifocal: 6.3  2.3 years; PAL:
7.3  2.8 years) and pharmaceuticals (6.4  2.6 years) tended to be
reserved for older children. Contact lenses were only considered
appropriate for older children, especially those intended speciﬁ-
cally for myopia control (single vision: 6.5  3.4 years; novel
myopia control soft: 8.8  3.1 years; orthokeratology: 8.8  3.1
years; multifocal: 8.9  3.1 years; RGPs 9.9  3.3 years). Most
practitioners did not recommend refractive surgery to patients
under 18 years of age. For single vision spectacles, bifocal
spectacles and PALs, European and Asian practitioners were more
conservative in their minimum ﬁtting age (p < 0.05) than Austral-
asian or North American practitioners. Asian and South Americanctitioners in different continents for progressing/young myopes. Data are expressed
stralasia Europe North America South America
.8  30.2 42.2  30.7 49.6  31.3 52.1  30.5
.3  4.4 2.1  7.0 5.1  13.6 1.9  7.0
.4  23.0 4.1  12.2 3.7  9.2 1.8  5.2
.6  2.1 6.1  13.6 2.4  8.3 6.8  10.8
.9  13.4 20.2  18.8 18.8  16.5 21.0  20.3
.2  11.9 4.3  11.0 8.5  17.5 2.1  7.2
.5  4.7 2.4  8.8 0.9  5.1 3.0  10.6
.2  29.1 18.3  27.6 9.4  18.5 7.9  25.2
.8  3.3 0.1  1.2 1.1  6.8 0.7  5.0
.3  1.3 0.3  1.6 0.6  4.5 2.8  7.6
Table 3
Minimum patient age considered necessary by practitioners (from different continents who prescribed these options for different myopia correction options. Data are
expressed as mean  S.D years (% that would not prescribe this refractive modality).
Continent
Technique Asia Australasia Europe North America South America
Spectacles Single Vision 5.9  3.9 (1) 5.3  0.5 (6) 7.4  3.0 (6) 5.2  0.6 (4) 5.5  1.2 (11)
Bifocals 6.6  2.6 (37) 6.0  1.3 (32) 7.4  2.6 (48) 5.1  0.5 (21) 7.5  2.9 (66)
Progressive Addition (PALs) 7.8  3.0 (21) 6.5  1.4 (14) 7.8  2.8 (47) 6.7  2.9 (23) 8.0  3.2 (65)
Contact Lenses Rigid Gas Permeable (RGP) 10.1  3.3 (20) 9.0  1.7 (32) 7.9  2.4 (22) 9.3  3.0 (24) 10.2  4.3 (24)
Single Vision Soft 10.9  3.8 (24) 8.3  0.8 (8) 7.8  2.7 (8) 7.9  2.4 (7) 10.3  3.7 (11)
Multifocal Soft 11.1  4.0 (52) 8.3  0.8 (22) 7.4  2.5 (45) 8.1  2.7 (24) 11.0  3.6 (63)
Speciﬁc Myopia Control Soft 10.8  3.5 (30) 8.3  0.8 (25) 7.3  2.5 (32) 7.9 2.6 (33) 10.3  3.9 (45)
Orthokeratology 9.6  3.2 (8) 8.0  1.1 (13) 8.1  2.3 (17) 8.0  3.1 (30) 12.3  4.8 (49)
Pharmaceutical 6.4  2.6 (44) 6.7  3.9 (65) 7.9  3.6 (87) 6.4  3.3 (62) 6.3  2.2 (64)
Refractive Surgery 16.9  2.9 (50) 18.0  0.0 (83) 12.8  4.5 (83) 18.0  0.0 (71) 15.5  5.2 (56)
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of all soft contact lens modalities than Australian, European or
North American practitioners (p < 0.01). There was no difference
between regions in the minimum age they would consider
prescribing RGP contact lenses, pharmaceuticals or refractive
surgery correction options (p > 0.05) .
Within Europe, practitioners from the Netherlands were the
most conservative in their minimum age for ﬁtting single vision
spectacles (p < 0.001). French practitioners were most conserva-
tive in their minimum age for ﬁtting single vision contact lenses
compared to those from the rest of the continent, with the
exception of Portuguese practitioners, who were conservative with
their minimum ﬁtting age of all types of contact lenses (p < 0.05).
Indian practitioners were more conservative than Chinese practi-
tioners on the minimum ﬁtting age for RGPs (p = 0.003), whereas
Chinese practitioners were more conservative in their minimum
ﬁtting age for single vision soft contact lenses than those from
either Hong Kong or India (p < 0.05). Orthokeratology was
considered at an earlier age in Hong Kong than India or China
(p < 0.001) and in the USA than in Canada (p = 0.029). Pharma-
ceuticals were considered at an earlier age in China than in Hong
Kong or India (p = 0.001).
3.7. Minimum degree of myopia that needs to be present for
practitioners to consider myopia control options (Table 4)
Overall practitioners indicated that myopia would be corrected
with single vision spectacles at a lower degree (1.07  0.90 D)
than it would with refractive surgery (3.06  1.62 D). All other
modalities would be considered at approximately 2.00 D. Asian
practitioners required a higher level of myopic refractive error
before they would consider single vision spectacles than all otherTable 4
Minimum level of patient myopia (in dioptres) before myopia correction options wou
options. Data are expressed as mean  S.D.
Continent
Technique Asia Au
Spectacles Single Vision 1.2  1.0 0
Bifocals 1.8  1.1 0
Progressive Addition (PALs) 2.1  1.4 0
Contact Lenses Rigid Gas Permeable (RGP) 3.1  1.9 2
Single Vision Soft 2.6  1.8 
Multifocal Soft 2.6  1.7 
Novel Myopia Control Soft 2.7  1.8 
Orthokeratology 2.4  1.5 
Pharmaceutical 1.6  1.5 
Refractive Surgery 3.5  1.6 2regions (p < 0.01). Australasian practitioners were willing to ﬁt
bifocals and PALs at a lower level of myopia than Asian, European
or South American clinicians (p < 0.01). North American practi-
tioners prescribed bifocal and PALs to children with a lower degree
of myopia than those from Asia (p = 0.001). However, Asian
practitioners would consider single vision soft contact lenses,
novel myopia control contact lenses, orthokeratology and phar-
maceutical intervention at a lower level of myopia than those from
Australasia or Europe (p < 0.01), and single vision soft contact
lenses and pharmaceutical treatment at a lower level of myopia
than those from North and South America (p < 0.01). Multifocal
contact lenses were considered at a lower level of myopia by
Australasian practitioners than those from Asia, Europe or South
America (p < 0.01). Asian practitioners required a higher level of
refractive error before they would consider ﬁtting RGPs than those
from Europe and North America (p < 0.01). Asian and European
practitioners would consider recommending refractive surgery at a
signiﬁcantly higher level of myopia than those from Australasia,
North or South America (p < 0.05). Within Europe, Portuguese and
French practitioners required a higher level of refractive error
before they would consider ﬁtting RGPs than those from other
European nations (p < 0.05). Portuguese practitioners also re-
quired a higher level of refractive error before they would consider
orthokeratology (p < 0.01) or refractive surgery (p < 0.001) than
practitioners from other European nations. Indian practitioners
required a higher level of refractive error before they would
consider bifocals (p < 0.05), PALs (p < 0.01) or orthokeratology
(p = 0.001) than practitioners from China or Hong Kong. Chinese
practitioners considered prescribing pharmaceuticals to children
with a lower level of myopia (0.66  0.4 D) compared to
practitioners from India (2.86  1.01 D) or Hong Kong
(2.39  1.75 D; p < 0.001). The only difference across Northld be considered by practitioners from different continents who prescribed these
stralasia Europe North America South America
.8  0.3 0.8  0.9 0.8  0.7 1.3  0.4
.8  0.4 1.8  1.4 1.1  0.7 1.5  0.0
.9  0.6 1.8  1.4 1.1  0.7 1.5  0.0
.8  1.4 2.2  1.8 1.5  1.4 1.8  0.4
1.8  0.9 1.1  0.8 0.9  0.7 1.5  0.0
1.8  1.0 1.9  1.5 1.1  0.7 1.5  0.0
1.7  0.9 1.9  1.5 1.5  1.2 1.5  0.0
1.6  0.8 2.3  1.6 1.5  1.2 1.5  0.0
2.1  0.9 3.1  1.6 1.5  1.3 2.5  2.1
.9  1.5 2.9  1.5 1.7  1.3 2.8  1.8
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refractive error before they would consider PALs (p = 0.012) than
those from the USA .
3.8. Minimum annual amount of patient myopia progression that
would prompt a practitioner to speciﬁcally adopt a myopia control
approach (Fig. 4)
The minimum myopia progression rate that practitioners
considered warranted a myopia control approach was
0.51–0.75 D/year for the majority of respondents (31.1%), with
74% indicating a level between 0.25 and 1.00 D/year. Australian
practitioners indicated that they would adopt myopia control
strategies for myopia progressing at slower rates than practitioners
from Asia, North or South American (p < 0.001). European
practitioners would be willing to treat myopia progression at
slower rates than those from Asian (p < 0.001) or South American
(p = 0.003). There were no differences in the minimum annual
myopia progression triggering a myopia control approach between
Europe (p = 0.090), Asia (p = 0.365) or North America (p = 0.057).
Other factors inﬂuencing practitioners’ management decisions, as
identiﬁed from the free text responses, included family history of
myopia (6 respondents), age of myopia onset (10 respondents),
absolute degree of refractive error at the time (2 respondents),
ocular biometry (3 respondents), environmental factors/lifestyle
(6 respondents), lighting exposure (3 respondents) and parental
decisions (3 respondents) .
3.9. Use of single-vision under-correction as a strategy to slow myopia
progression (Fig. 5)
Overall, most practitioners did not consider single-vision
distance under-correction to be an effective strategy for attenuat-
ing myopia progression (72.7%). South American practitioners used
this strategy relatively more than those from Australia, Asia or
North America (p < 0.01). Within Europe, Spanish and Portuguese
practitioners indicated using under-correction as a strategy toFig. 4. Minimum annual amount of patient myopia progression, in dioptres per year (D
myopia control approach. N = 964.control myopia more than those from the UK and EIRE (p < 0.05).
Within Asia, Indian practitioners utilised under-correction more
than those from China or Hong Kong (p < 0.001). Within North
America, there was no difference in the use of under-correction
between the USA and Canada (p = 0.719) .
3.10. Factors preventing the prescription of a myopia control approach
(Fig. 6)
The most common reasons practitioners gave for not adopting
myopia control strategies were: they were felt to be uneconomical
(35.6%); they considered there to be inadequate information about
the modalities (33.3%); they viewed the outcomes to be
unpredictable (28.2%); concerns about safety (25.3%); they
perceived them to be ineffective for reducing myopia progression
(23.8%); and the beneﬁt to risk ratio was too low (20.5%). There was
no signiﬁcant difference in the distribution of these factors
between or within continents (p > 0.05). Free text comments
identiﬁed other factors affecting the prescription of these
strategies to relate to the relative availability of the myopia
control treatments and the instrumentation necessary to prescribe
them, and the need for consistent regulations and informational
materials .
4. Discussion
This is the ﬁrst study to examine the self-reported attitudes and
practices of eye care practitioners towards myopia control
approaches across the globe. Close to one thousand practitioners
responded, principally spread over ﬁve continents. The exact
response rate is not known, as maximum coverage was promoted
by involving professional bodies whose members may not all be
practicing eye care practitioners. However, it may be presumed
that questionnaires are completed both by people cynical and
enthusiastic to the issue being examined, balancing the average
response. In addition, the recruitment approach across nations was
the same, allowing cross-national comparisons. The majority of the/year), that practitioners located in different continents considered to necessitate a
Fig. 5. Use of single-vision distance under-correction as a strategy to slow myopia progression by practitioners located in different continents. N = 964.
J.S. Wolffsohn et al. / Contact Lens & Anterior Eye 39 (2016) 106–116 113respondents (91.0%) were optometrists and ophthalmologists,
reﬂecting those professions legally allowed to prescribe vision care
correction and, in many regions, pharmaceuticals as well.
As one might expect from the high prevalence rates of myopia
in Asia, Asian practitioners, especially those practicing in China,
were more concerned about the increasing prevalence of
paediatric myopia in their practices than clinicians in any of the
other continents. A similar pattern existed in relation to how active
they considered their clinical practice in the area of myopia control.
Myopia prevalence was approximately 30% in 30–35 year olds in
Spain [105] and may be increasing in Portugal [106], but is as high
as 58% in Italian university students and 28% in Dutch school
children [107]; hence it is unclear why the former country’sFig. 6. Factors preventing practitioners located in different contipractitioners are more concerned than the latter. The prevalence of
myopia in the USA was around 30% [11], but the myopia occurrence
is not documented in Canada to warrant their lower concern.
Orthokeratology was correctly perceived by eye care practi-
tioners to be one of the most effective methods for attenuating
childhood myopia progression. However, the effectiveness of
pharmaceutical approaches were underestimated by practi-
tioners and increased time spent outdoors overestimated
compared to current evidence (Fig. 1). Differences in lifestyle,
such as population density might affect perceived effectiveness of
approached such as perceived time spent outdoors. While single-
vision distance under-correction has been shown fairly conclu-
sively to increase, rather than decrease, the rate of myopianents from prescribing a myopia control approach. N = 964.
114 J.S. Wolffsohn et al. / Contact Lens & Anterior Eye 39 (2016) 106–116progression in children [57,58], there were still practitioners who
consider the converse to be true; this was conﬁrmed by a question
later in the survey, with under-correction still practiced as a
method of myopia control particularly by practitioners from
South America, Spain and Portugal within Europe and India
within Asia.
Despite the self-perceived activity of practitioners in the area of
myopia control, over two thirds of progressing and/or young
myopes were being prescribed single vision spectacles or contact
lenses (68%), with continental and national differences in the
adoption of refractive correction options known to reduce myopia
progression. Approximately one third of practitioners not adopting
myopia control approaches felt them to be uneconomical and/or
that there was inadequate information about them; about one
quarter of respondents suggested that outcomes were unpredict-
able and/or that myopia control methods were ineffective, with
some also being concerned about the relative safety of these
strategies. Further comments raised the issue of availability of
some myopia control options, presumably of novel myopia control
lenses, as current approaches are all off-label, highlighting the
need for regulatory oversight and guidance. Limited access to
necessary instrumentation was also raised as a potential barrier, as
more advanced contact lens ﬁttings, such as orthokeratology,
require the use of corneal topography. Attempts to speciﬁcally
manipulate peripheral retinal focus may also require instrumen-
tation to rapidly and robustly assess peripheral retinal shape and/
or refraction with myopia control ophthalmic medical devices.
However, this strategy might not ‘translate’ well from animal
studies to human trials [79,80].
Spherical equivalent refractive error (measured under cyclo-
plegia) is currently the single best predictive measure of juvenile
myopia development, with children aged six years with less than
+0.75D of hyperopia being at increased risk of developing myopia
[108]. Most practitioners were comfortable ﬁtting refractive
corrections with basic optical designs and even pharmaceuticals
to myopic patients of this age, but tended to wait until a child was
older for more complex designs such as PALs, novel myopia control
soft contact lenses and RGPs (including orthokeratology). Inter-
estingly, one potential advantage of orthokeratology is that the
parents or carer can manage lens application, removal and lens
care, along with the lenses not having to leave the home, which can
make this modality a popular option for parents or carers with
younger myopic children. This is exempliﬁed by Hong Kong, an
early adopter of orthokeratology, where its use is considered at an
earlier age than other countries in the region.
Research suggests that lower levels of hypermetropia at a young
age is a strong risk factor for myopia development, so it would
seem that practitioners are far too conservative in waiting until
mild-moderate levels of myopia are present before control
approaches are considered [80,108]. Myopia progresses at much
faster rates in children in comparison to teenagers, thus supporting
the need for earlier intervention [109]. There may also “window of
opportunity” for myopia treatment according to the age of onset,
rate of progression and myopia magnitude [110]. More research is
needed on the relative beneﬁts of myopia control strategies in
adolescents and even young adults. Practitioners located in Asia
considered most myopia control approaches at a lower level of
myopia than other continents, which is presumably due to this
continent having one of the highest prevalences of myopia
worldwide. Interestingly, Chinese practitioners considered pre-
scribing pharmaceutical modalities at a younger age, and at a much
lower level of myopia, compared with practitioners from other
countries in the region. This may be due to different countries
having different regulations and practitioners with different
background (for example training, education and scope of
practice), which can affect local practice, apart from the prevalenceof myopia and need for correction or retardation. The rate of
patient refractive progression that triggered practitioners to
prescribe a myopia control approach largely mirrored the
prevalence rate of myopia in each region; the higher the prevalence
of myopia, the higher the level of myopia developed in individuals
and the higher the risk of ocular pathology [20]. Practitioners
understandably also identiﬁed several other factors that, combined
with the degree of myopic progression, inﬂuenced their decision to
prescribe myopia control approaches; these included family
history, age of onset, absolute amount of refractive error at that
time, ocular biometry, environmental factors/lifestyle, lighting
exposure and the degree of parental support [111].
In conclusion, this global survey of current trends in eye care
practitioner myopia management attitudes and strategies in
clinical practice has identiﬁed that, despite growing evidence of
the negative impact of even low levels of myopia on health
economics, and moderate levels of practitioner concern and
perceived activity (particularly where the prevalence of myopia is
highest), uptake of appropriate techniques is generally poor.
Furthermore, myopia control techniques are not being applied
early enough in a child’s ocular development to elicit their
optimum effect. Adequate education of practitioners is lacking,
along with access to appropriately regulated myopia control
‘labelled’ products with efﬁcacy and safety data. A guide needs to
be developed to inform practitioners of economically viable
models of eye care, including the development of instrumentation
to enhance management selection, which address the myopia
epidemic to reduce the growing health burden.
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